Institutions / Remedium Capital Partners, LLC / Activity
Activity — Remedium Capital Partners, LLC
6 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Q2 2026 as of | Add | 36322Q206 Common stock | $50.07M | +1.9M +1597.87% | 2,045,473 11.78% of portfolio | high |
| Q2 2026 as of | New | Crescent Biopharma, Inc. Common stock | $6.50M | +361K | 361,250 1.44% of portfolio | medium |
| Q2 2026 as of | Add | Oruka Therapeutics, Inc. Common stock | $1.26M | +13K +0.85% | 1,565,661 32.99% of portfolio | low |
| Q2 2026 as of | Add | Spyre Therapeutics, Inc. Common stock | $704.7K | +8K +0.55% | 1,464,169 28.78% of portfolio | low |
| Q2 2026 as of | Add | Apogee Therapeutics, Inc. Common stock | $411.5K | +3K +0.53% | 586,691 17.24% of portfolio | low |
| Q2 2026 as of | Exit | Crescent Biopharma, Inc. Common stock | $-4.3K | -361K -100.00% | 0 | low |